[1]吴君华,吴友茹,李 丹.血清降钙素原在AECOPD抗感染治疗中的应用价值研究[J].医学信息,2018,31(02):74-76.[doi:10.3969/j.issn.1006-1959.2018.02.025]
　WU Jun-hua,WU You-ru,LI Dan.Study on the Application Value of Serum Calcitonin in the Anti Infection Treatment of AECOPD[J].Journal of Medical Information,2018,31(02):74-76.[doi:10.3969/j.issn.1006-1959.2018.02.025]
点击复制

血清降钙素原在AECOPD抗感染治疗中的应用价值研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年02期
页码:
74-76
栏目:
论著
出版日期:
2018-01-15

文章信息/Info

Title:
Study on the Application Value of Serum Calcitonin in the Anti Infection Treatment of AECOPD
文章编号:
1006-1959（2018）02-0074-03
作者:
吴君华; 吴友茹; 李 丹
绵阳市中心医院呼吸内科，四川 绵阳 621000
Author(s):
WU Jun-hua; WU You-ru; LI Dan
Department of Respiratory Medicine,Mianyang Central Hospital,Mianyang 621000,Sichuan,China
关键词:
降钙素原; 慢性阻塞性肺疾病急性加重期; 抗生素
Keywords:
Key words：Procalcitonin; Acute exacerbation of chronic obstructive pulmonary disease; Antibiotics
分类号:
R563.9
DOI:
10.3969/j.issn.1006-1959.2018.02.025
文献标志码:
A
摘要:
目的 探讨血清降钙素原在慢性阻塞性肺疾病急性加重期抗感染治疗中的变化水平，评价其指导使用抗生素的临床价值。方法 选取2013年9月~2016年9月我科收治的264例 AECOPD患者，随机分为PCT组和对照组，每组132例。对照组患者根据医生临床经验决定是否接受抗生素治疗。PCT组根据血清PCT水平决定抗生素治疗，PCT水平≥0.25 μg/L时应用抗生素，当PCT水平＜0.25 μg/L时停用抗生素。比较两组患者抗生素的使用率及使用时间、住院时间、二重感染、呼吸机辅助通气、死亡率和临床有效率等指标。结果 PCT组患者抗生素使用率（50.76%）显著低于对照组（78.03%），差异有统计学意义（P=0.000）；PCT组抗生素平均使用时间短于对照组[（6.2±2.4）d vs（11.5±3.6）d]，差异有统计学意义（P=0.000）；PCT 组患者平均住院天数相比对照组更短，差异有统计学意义（P=0.000）。PCT组和对照组白细胞计数、二重感染发生率、呼吸机辅助通气例数、死亡率、临床治疗有效率差异均无统计学意义（P＞0.05）。结论 PCT可作为指导 AECOPD抗生素使用的一项重要指标，提高抗生素的合理使用，降低二重感染，减少住院时间。
Abstract:
Abstract：Objective To investigate the changes of serum procalcitonin in the anti-infective therapy of acute exacerbation of chronic obstructive pulmonary disease(COPD),and to evaluate its clinical value in guiding the use of antibiotics.Methods A total of 264 patients with AECOPD admitted to our department from September 2013 to September 2016 were randomly divided into the PCT group and the control group,with 132 cases in each group.The patients in the control group were treated with antibiotics according to their clinical experience.PCT group according to the serum PCT levels of antibiotic therapy,antibiotics application level of PCT≥0.25 g/L,when the PCT level is ＜0.25μg/L when the discontinuation of antibiotics.The use of two groups were compared the rate of antibiotics and the use of time,hospitalization time,double infection,mechanical ventilation,mortality and clinical efficiency and other indicators.Results In group PCT,the antibiotic use rate(50.76%)was significantly lower than the control group(78.03%),the difference was statistically significant(P=0.000);The mean duration of antibiotic use in the PCT group was shorter than that in the control group[(6.2±2.4) d vs(11.5±3.6)d],The difference was statistically significant(P=0.000).The mean hospital stay in PCT group was shorter than that in control group,the difference was statistically significant(P=0.000).The PCT group and control group had no significant differences in white blood cell count,incidence of double infection,ventilatory-assisted ventilation, mortality and clinical treatment efficiency(P＞0.05).Conclusion PCT can be used as a guideline for the use of AECOPD antibiotics as an important indicator to improve the rational use of antibiotics,reduce double infection and reduce hospital stay.

参考文献/References:

[1]中国呼吸科专家组（统称）,慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组.慢性阻塞性肺疾病急性加重诊治中国专家共识（2014年修订版）[J].国际呼吸杂志,2014,34(1):1-11.
[2]许欣宜,杜冀辉,张会生.定量与半定量检测血清降钙素原在细菌感染诊断中的应用价值评价[J].国际检验医学杂志,2013,34(18):2385-2387.
[3]顾剑玲,王婷,马薇,等.布地奈德治疗慢性阻塞性肺疾病急性加重临床疗效观察 [J].医学综述,2011,17(17):2704-2706.
[4]Limper M,de Kruif MD,Duits AJ,et al.The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever[J]．J Infect,2010 ,60(6):409-416.
[5]丁海波, 林其昌,陈公平,等.血清降钙素原在慢性阻塞性肺疾病急性加重期抗菌治疗中的指导作用[J].中华老年医学杂志,2012,31(5): 396-398.
[6]马静,李红兵,张禧捷,等.血清降钙素原、超敏C反应蛋白在肺炎合并脓毒症患者中的临床意义[J].中国实用医药,2014,9(2):124-125.
[7]降钙素原急诊临床应用专家共识组．降钙素原 (PCT ) 急诊临床应用的专家共识[J].中华急诊医学杂志,2012,21(9):945．
[8]虞意华,严静,龚仕金,等.血清 PCT 水平指导老年下呼吸道持续细菌定植者抗生素治疗的价值[J].浙江实用医学,2010,15(4):268-269.
[9]王巍,张章.血清降钙素原在慢性阻塞性肺疾病急性加重期的诊断及评估应用[J].四川医学,2015,36(6):851-853.
[10]李珍,徐鸥.降钙素原在慢性阻塞性肺疾病急性加重期的应用及进展[J].临床肺科杂志,2015(4):728-732.
[11]李迅,陈长山,胡义萍,等.降钙素原指导慢性阻塞性肺病急性加重期抗菌药物使用的价值[J].安徽医学,2016,37(1):58-60.
[12]Koutsokera A,Stolz D,Loukides S,et al．Systemic biomarkers in exacerbations of COPD：the evolving clinical challenge[J].Chest,2012,141(2):396-405．

相似文献/References:

[1]刘 亮.PCT和CRP联合检测对儿童呼吸道感染的临床意义[J].医学信息,2018,31(02):154.[doi:10.3969/j.issn.1006-1959.2018.02.059]
　LIU Liang.Clinical Significance of Combined Detection of PCT and CRP in Children with Respiratory Tract Infection[J].Journal of Medical Information,2018,31(02):154.[doi:10.3969/j.issn.1006-1959.2018.02.059]
[2]高艳飞.降钙素原对新生儿感染性肺炎的早期诊断价值研究[J].医学信息,2018,31(03):154.[doi:10.3969/j.issn.1006-1959.2018.03.056]
　GAO Yan-fei.Study on the Value of Procalcitonin in the Early Diagnosis of Neonatal Infectious Pneumonia[J].Journal of Medical Information,2018,31(02):154.[doi:10.3969/j.issn.1006-1959.2018.03.056]
[3]李 娟,田 鹏,刘 琦,等.血清降钙素原在儿童发热性疾病中的应用价值分析[J].医学信息,2018,31(04):102.[doi:10.3969/j.issn.1006-1959.2018.04.034]
　LI Juan,TIAN Peng,LIU Qi,et al.Analysis of the Value of Serum Procalcitonin in Children with Febrile Diseases[J].Journal of Medical Information,2018,31(02):102.[doi:10.3969/j.issn.1006-1959.2018.04.034]
[4]许 俊.慢性阻塞性肺疾病急性加重期与慢性阻塞性肺疾病并发社区获得性肺炎患者的临床对比[J].医学信息,2018,31(22):118.[doi:10.3969/j.issn.1006-1959.2018.22.033]
　XU Jun.Clinical Comparison of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Complicated with Community Acquired Pneumonia[J].Journal of Medical Information,2018,31(02):118.[doi:10.3969/j.issn.1006-1959.2018.22.033]
[5]付云杰.超敏C反应蛋白、前清蛋白及降钙素原在重症肺炎患者中的变化及诊断的临床意义[J].医学信息,2018,31(24):84.[doi:10.3969/j.issn.1006-1959.2018.24.022]
　FU Yun-jie.Changes of Hypersensitive C-reactive Protein,Proalbumin and Procalcitonin in Patients with Severe Pneumonia and Its Clinical Significance[J].Journal of Medical Information,2018,31(02):84.[doi:10.3969/j.issn.1006-1959.2018.24.022]
[6]刘伟娜.CD64感染指数、BODE指数与降钙素原在慢阻肺患者中的水平变化[J].医学信息,2019,32(06):125.[doi:10.3969/j.issn.1006-1959.2019.06.039]
　LIU Wei-na.Changes of CD64 Infection Index,BODE Index and Procalcitonin Levels in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2019,32(02):125.[doi:10.3969/j.issn.1006-1959.2019.06.039]
[7]田 刚,丁俊杰,宋 敏,等.两种不同检测系统测定血清降钙素原的比较实验研究[J].医学信息,2019,32(06):169.[doi:10.3969/j.issn.1006-1959.2019.06.055]
　TIAN Gang,DING Jun-jie,SONG Min,et al.Comparative Experimental Study on Serum Procalcitonin by Two Different Detection Systems[J].Journal of Medical Information,2019,32(02):169.[doi:10.3969/j.issn.1006-1959.2019.06.055]
[8]张文旭,徐 绸.红细胞宽度对脓毒症患者病情诊断及预后评估的价值[J].医学信息,2022,35(14):71.[doi:10.3969/j.issn.1006-1959.2022.14.015]
　ZHANG Wen-xu,XU Chou.The Value of Red-blood-cell Distribution Width in the Diagnosis and Prognosis of Patients with Sepsis[J].Journal of Medical Information,2022,35(02):71.[doi:10.3969/j.issn.1006-1959.2022.14.015]
[9]朱津津.PCT 联合SAA在急性胆管炎患者诊疗中的价值[J].医学信息,2019,32(18):170.[doi:10.3969/j.issn.1006-1959.2019.18.060]
　ZHU Jin-jin.The Value of PCT Combined with SAA in the Diagnosis and Treatment of Patients with Acute Cholangitis[J].Journal of Medical Information,2019,32(02):170.[doi:10.3969/j.issn.1006-1959.2019.18.060]
[10]牛瑞兵.中性粒细胞CD64、PCT联合CRP诊断儿童脓毒血症的价值[J].医学信息,2019,32(19):180.[doi:10.3969/j.issn.1006-1959.2019.19.061]
　NIU Rui-bing.The Value of Neutrophil CD64,PCT Combined with CRP in the Diagnosis of Sepsis in Children[J].Journal of Medical Information,2019,32(02):180.[doi:10.3969/j.issn.1006-1959.2019.19.061]

更新日期/Last Update: 2018-02-15